With the Food and Drug Administration reportedly planning to propose stricter guidelines for emergency approval of a coronavirus vaccine, President Donald Trump late Wednesday threatened to block the agency’s push for tougher standards because he trusts for-profit pharmaceutical corporations to conduct adequate safety testing.
“I have tremendous trust in these massive companies that are so brilliantly organized in terms of what they’ve been doing with the tests. I don’t know that a government as big as we are could do tests like this,” Trump said during a press briefing, minimizing the central role the federal government has played in coordinating and providing much of the funding for vaccine trials.
Asked specifically about the FDA’s push for stricter vaccine guidelines, the president declared that any revisions to existing standards “have to be approved by the White House.” The FDA declined to comment when a CNN reporter asked about the president’s remarks.
“We may or may not approve it,” Trump said. “That sounds like a political move, because when you have Pfizer, Johnson & Johnson, Moderna, these great companies coming up with the vaccines and they’ve done testing and everything else, I’m saying why would they have to be, you know, adding great length to the process?”
Watch:
President Trump said today that the White House may not approve tougher FDA guidelines for authorizing the emergency use of any coronavirus vaccines.
"That has to be approved by the White House," he said of the FDA guidance. "We may or may not approve it" https://t.co/aLppEdJXFx pic.twitter.com/UpDkEOOtWd
— POLITICO (@politico) September 24, 2020
Trump’s decision to publicly undercut the FDA came amid growing concerns among experts and lawmakers that the president is putting public safety at risk by pushing for the speedy approval of a coronavirus vaccine in an effort to boost his reelection chances.
“Everybody wants a vaccine, but we want to make sure that that vaccine is safe,” Sen. Bernie Sanders (I-Vt.) said earlier this month. “We don’t want to see that vaccine put on the market for political reasons.”
The New York Times reported Tuesday that the new guidance the FDA is expected to propose as early as this week “would lay out more specific criteria for clinical trial data and recommend that the data be vetted by a committee of independent experts before the FDA authorizes any vaccine. The guidelines would be the most detailed description yet by the federal government about how the vaccine vetting process will proceed.”
UPDATE: Trump’s comments came hours after he was briefed on the guidance by HHS Secretary Alex Azar.
The opposition within the White House also caught FDA by surprise – these stricter rules had been widely circulated and cleared through HHS yesterday https://t.co/8mwjK6g5j7
— Adam Cancryn (@adamcancryn) September 24, 2020
In a statement Wednesday, Eli Zupnick, spokesperson for watchdog group Accountable Pharma, warned Trump against meddling with the FDA’s vaccine guidelines, saying the stricter standards would be “an important step in restoring the public trust that Trump has undermined.”
“Trump and his political appointees have inappropriately pressured, intimidated, and overruled career public health officials too many times already, but the stakes are far too high for that to happen again with this upcoming FDA guidance,” said Zupnick. “Trump’s White House must not block or water down this guidance and must allow scientists and public health officials, not Trump’s political interests, to guide this vaccine approval process.”
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.